Abstract
Heparin-induced thrombopenia is a common autoimmune complication. It is a prothrombotic state due to the formation of antibodies against heparin/platelet factor 4 complexes. In this situation drugs other than heparin must be used for anticoagulation during extracorporeal circulation (bypass) surgery.Two cases of heart transplantation are presented in whom bivalirudin was used as an anticoagulant during the cardiopulmonary bypass. Severe bleeding complications were observed in both patients.The diagnosis of heparin-induced thrombopenia needs to be improved, as well as the development of protocols for using new drugs other than heparin. For this reason, we have reviewed current protocols and alternative therapies to heparin. © 2011 Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor.
Original language | English |
---|---|
Pages (from-to) | 407-410 |
Journal | Revista Espanola de Anestesiologia y Reanimacion |
Volume | 60 |
Issue number | 7 |
DOIs | |
Publication status | Published - 1 Aug 2013 |
Keywords
- Anticoagulation
- Bivalirudin
- Bleeding
- Extracorporeal circulation
- Heart transplant
- Heparin-induced thrombopenia